Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, ...
Pfizer is in early talks to acquire cancer-focused biotech Seagen, The Wall Street Journal reported. Seagen shares surged almost 11%, while Pfizer's slipped on Monday after the report. The potential ...
When it comes to churning out medicines that fight cancer, Seagen (NASDAQ: SGEN) is a heavyweight. The biotech's global footprint is expanding thanks to regulatory approvals in Europe, and its sales ...
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding ...
Scoring two of the three largest M&A deals in biopharma last year was just an appetizer for Pfizer. On Monday, the industry giant sat down to the main course, gobbling up Seattle cancer specialist ...
Pfizer (NYSE:PFE) is accelerating its transformation with acquisitions of Seagen and Metsera to expand in oncology and anti obesity treatments. The company is dealing with lower COVID related revenues ...
Pfizer is set to acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise ...
Pfizer Inc. agreed to purchase cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, gaining the company’s antibody drugs that fight tumors. Pfizer will pay $229 a share in cash for ...
Seagen fielded multiple offers before agreeing to a whopping $43 billion acquisition by pharma giant Pfizer. The Seattle-area company revealed negotiation details with several companies in a recent ...
Read full article: Judge blocks Florida’s Atlantic red snapper season hours before Memorial Day weekend start An empty fountain near Constellation Carousel at Epic Universe. Read full article: ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE - A man walks by Pfizer headquarters, Friday, Feb. 5, 2021, in New York. Pfizer will spend about $43 billion to buy Seagen ...